{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:08:29Z","timestamp":1792642109011,"version":"4.5.0"},"reference-count":115,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Postinfectious inflammatory arthritis can result from various pathogens, including bacteria, viruses, fungi, and parasites. Prompt identification and treatment of acute infection is vital, but some cases progress to chronic arthritis despite successful treatment of infection. Postinfectious inflammatory arthritis varies from mild, self-limited arthralgia to severe, refractory arthritis, necessitating ongoing disease-modifying treatment. This review explores the spectrum of postinfectious inflammatory arthritis to provide insights into effective management.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Research continues regarding the benefit of antimicrobial therapy, beyond treatment of the acute infection, to diminish the severity of postinfectious inflammatory arthritis. Following treatment of acute infection, most cases are self-limited so treatment is symptomatic. However, a difficult-to-predict fraction of cases develop chronic postinfectious inflammatory arthritis that can be challenging to manage. Recently, as more biologic, and targeted synthetic DMARDs have become available, treatment options have expanded.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>In this article, we use the term \u2018postinfectious inflammatory arthritis\u2019 rather than \u2018reactive arthritis\u2019 because it describes a broader spectrum of diseases and emphasizes the common pathogenesis of a postinfectious inflammatory process. We summarize the conventional therapies and recent management developments for the most frequently encountered postinfectious inflammatory arthritides.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000001009","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T12:00:24Z","timestamp":1709035224000},"page":"155-162","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Management of postinfectious inflammatory arthritis"],"prefix":"10.1097","volume":"36","author":[{"given":"Hailey","family":"Baker","sequence":"first","affiliation":[{"name":"Section of Rheumatology, Allergy, and Immunology, Yale School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Kennedy","family":"Amaral","sequence":"additional","affiliation":[{"name":"Institute of Diagnostic Medicine of Cariri, Juazeiro do Norte, Cear\u00e1, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert T.","family":"Schoen","sequence":"additional","affiliation":[{"name":"Section of Rheumatology, Allergy, and Immunology, Yale School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,2,21]]},"reference":[{"key":"R1-20250526","first-page":"1065","article-title":"Reactive arthritis: current treatment challenges and future perspectives","volume":"37","author":"Lucchino","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"R2-20250526","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11926-020-00904-9","article-title":"Reactive arthritis: treatment challenges and future perspectives","volume":"22","author":"Wendling","year":"2020","journal-title":"Curr Rheumatol Rep"},{"key":"R3-20250526","doi-asserted-by":"crossref","first-page":"e002519","DOI":"10.1136\/rmdopen-2022-002519","article-title":"Reactive arthritis after SARS-CoV-2 infection","volume":"8","author":"Dombret","year":"2022","journal-title":"RMD Open"},{"key":"R4-20250526","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11926-021-01004-y","article-title":"Reactive arthritis following bacillus Calmette-Guerin therapy for bladder cancer: a systematic literature review","volume":"23","author":"Abdelghani","year":"2021","journal-title":"Curr Rheumatol Rep"},{"key":"R5-20250526","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jiac.2021.12.028","article-title":"Surgically treated reactive arthritis of the ankle after COVID-19 infection: a case report","volume":"28","author":"Shimoyama","year":"2022","journal-title":"J Infect Chemother"},{"key":"R6-20250526","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s13018-023-03651-6","article-title":"Reactive arthritis following COVID-19 current evidence, diagnosis, and management strategies","volume":"18","author":"Migliorini","year":"2023","journal-title":"J Orthop Surg Res"},{"key":"R7-20250526","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/mrcr\/rxad002","article-title":"Reactive arthritis after Gam-COVID-Vac vaccination: a case report","volume":"7","author":"Shokraee","year":"2023","journal-title":"Mod Rheumatol Case Rep"},{"key":"R8-20250526","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/1756-185X.14411","article-title":"Reactive synovitis of the knee joint after COVID-19 vaccination: the first ultrastructural analysis of synovial fluid","volume":"25","author":"Vanaskova","year":"2022","journal-title":"Int J Rheum Dis"},{"key":"R9-20250526","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2106\/JBJS.CC.21.00207","article-title":"Reactive arthritis from influenza vaccination: a novel presentation that mimics prosthetic joint infection: a case report","volume":"11","author":"Bell","year":"2021","journal-title":"JBJS Case Connect"},{"issue":"(319)","key":"R10-20250526","first-page":"100","article-title":"Inactivated Covid-19 vaccine can induce reactive polyarthritis in older patients: report of two cases","author":"Turk","year":"2021","journal-title":"Georgian Med News"},{"key":"R11-20250526","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1080\/21645515.2021.1920274","article-title":"Reactive arthritis after COVID-19 vaccination","volume":"17","author":"An","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"R12-20250526","first-page":"325","article-title":"Similarity between chronic reactive arthritis and ankylosing spondylitis. a 32-35-year follow-up study","volume":"27","author":"Kaarela","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"R13-20250526","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1136\/ard.2003.010710","article-title":"Three month treatment of reactive arthritis with azithromycin: a EULAR double blind, placebo controlled study","volume":"63","author":"Kvien","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"R14-20250526","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/1529-0131(199907)42:7<1386::AID-ANR12>3.0.CO;2-E","article-title":"No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: a three-month, multicenter, double-blind, randomized, placebo-controlled study","volume":"42","author":"Sieper","year":"1999","journal-title":"Arthritis Rheum"},{"key":"R15-20250526","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/art.27394","article-title":"Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial","volume":"62","author":"Carter","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R16-20250526","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1136\/ard.62.9.880","article-title":"Effect of a three month course of ciprofloxacin on the late prognosis of reactive arthritis","volume":"62","author":"Yli-Kerttula","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"R17-20250526","doi-asserted-by":"crossref","first-page":"916","DOI":"10.3899\/jrheum.121192","article-title":"Antibiotics for treatment of reactive arthritis: a systematic review and metaanalysis","volume":"40","author":"Barber","year":"2013","journal-title":"J Rheumatol"},{"key":"R18-20250526","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/01.rhu.0000182153.18181.81","article-title":"Successful treatment of postvenereal reactive arthritis with synovectomy and 3 months\u2019 azithromycin","volume":"11","author":"Pavlica","year":"2005","journal-title":"J Clin Rheumatol"},{"key":"R19-20250526","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1002\/art.1780391211","article-title":"Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome). A Department of Veterans Affairs Cooperative Study","volume":"39","author":"Clegg","year":"1996","journal-title":"Arthritis Rheum"},{"key":"R20-20250526","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2177\/jsci.33.283","article-title":"Efficacy of methotrexate in the treatment of a HLA-B27-positive Japanese patient with reactive arthritis","volume":"33","author":"Nanke","year":"2010","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"R21-20250526","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/ard.45.8.653","article-title":"A placebo controlled, crossover study of azathioprine in Reiter's syndrome","volume":"45","author":"Calin","year":"1986","journal-title":"Ann Rheum Dis"},{"key":"R22-20250526","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0161-6420(03)00620-1","article-title":"Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter's syndrome","volume":"110","author":"Kiss","year":"2003","journal-title":"Ophthalmology"},{"key":"R23-20250526","doi-asserted-by":"crossref","first-page":"e002693","DOI":"10.1136\/rmdopen-2022-002693","article-title":"Long-term follow-up of certolizumab pegol in uveitis due to immune-mediated inflammatory diseases: multicentre study of 80 patients","volume":"8.","author":"Martin-Varillas","year":"2022","journal-title":"RMD Open"},{"key":"R24-20250526","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1002\/art.1780401010","article-title":"Crucial role of interleukin-10\/interleukin-12 balance in the regulation of the type 2\u200aT helper cytokine response in reactive arthritis","volume":"40","author":"Yin","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"(6 Suppl 28)","key":"R25-20250526","first-page":"S130","article-title":"TNF involvement and anti-TNF therapy of reactive and unclassified arthritis","volume":"20","author":"Meador","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"R26-20250526","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/cei.12799","article-title":"Recombinant Salmonella typhimurium outer membrane protein A is recognized by synovial fluid CD8 cells and stimulates synovial fluid mononuclear cells to produce interleukin (IL)-17\/IL-23 in patients with reactive arthritis and undifferentiated spondyloarthropathy","volume":"185","author":"Chaurasia","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"R27-20250526","first-page":"2285","article-title":"Th1\/Th17 cytokine profiles in patients with reactive arthritis\/undifferentiated spondyloarthropathy","volume":"34","author":"Singh","year":"2007","journal-title":"J Rheumatol"},{"key":"R28-20250526","doi-asserted-by":"crossref","first-page":"BSR20191927","DOI":"10.1042\/BSR20191927","article-title":"Treatment of reactive arthritis with biological agents: a review","volume":"40","author":"Zeng","year":"2020","journal-title":"Biosci Rep"},{"key":"R29-20250526","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00296-009-0965-9","article-title":"Infliximab for reactive arthritis secondary to Chlamydia trachomatis infection","volume":"30","author":"Schafranski","year":"2010","journal-title":"Rheumatol Int"},{"key":"R30-20250526","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jbspin.2016.05.002","article-title":"Early treatment of reactive arthritis with etanercept and 2\u200ayears follow-up","volume":"84","author":"Courcoul","year":"2017","journal-title":"Joint Bone Spine"},{"key":"R31-20250526","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10067-007-0692-0","article-title":"Successful use of infliximab in the treatment of Reiter's syndrome: a case report and discussion","volume":"27","author":"Gill","year":"2008","journal-title":"Clin Rheumatol"},{"key":"R32-20250526","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/art.30272","article-title":"Safety and efficacy of antitumor necrosis factor alpha therapy in ten patients with recent-onset refractory reactive arthritis","volume":"63","author":"Meyer","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R33-20250526","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1002\/art.24899","article-title":"Successful treatment of reactive arthritis with a humanized antiinterleukin-6 receptor antibody, tocilizumab","volume":"61","author":"Tanaka","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R34-20250526","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/mrcr\/rxab014","article-title":"Secukinumab therapy in reactive arthritis: report of two cases","volume":"6","author":"Padhan","year":"2022","journal-title":"Mod Rheumatol Case Rep"},{"key":"R35-20250526","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4103\/ijdvl.IJDVL_519_18","article-title":"A retrospective case series of 12 patients with chronic reactive arthritis with emphasis on treatment outcome with biologics","volume":"87","author":"Gupta","year":"2021","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R36-20250526","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/mrcr\/rxab029","article-title":"Successful use of tofacitinib in reactive arthritis refractory to conventional therapies - a case series","volume":"6","author":"Maikap","year":"2022","journal-title":"Mod Rheumatol Case Rep"},{"key":"R37-20250526","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1136\/ard.58.7.410","article-title":"A clinical and serological comparison of group A versus nongroup A streptococcal reactive arthritis and throat culture negative cases of poststreptococcal reactive arthritis","volume":"58","author":"Jansen","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"R38-20250526","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/BOR.0b013e328337ba26","article-title":"Acute rheumatic fever and poststreptococcal reactive arthritis reconsidered","volume":"22","author":"van der Helm-van Mil","year":"2010","journal-title":"Curr Opin Rheumatol"},{"key":"R39-20250526","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11926-021-00982-3","article-title":"Update on post-streptococcal reactive arthritis: narrative review of a forgotten disease","volume":"23","author":"Ahmed","year":"2021","journal-title":"Curr Rheumatol Rep"},{"key":"R40-20250526","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/art.24401","article-title":"No increased risk of valvular heart disease in adult poststreptococcal reactive arthritis","volume":"60","author":"van Bemmel","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R41-20250526","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/00006454-198810000-00002","article-title":"Prognosis of children with poststreptococcal reactive arthritis","volume":"7","author":"De Cunto","year":"1988","journal-title":"Pediatr Infect Dis J"},{"key":"R42-20250526","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1161\/CIRCULATIONAHA.109.191959","article-title":"Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics","volume":"119","author":"Gerber","year":"2009","journal-title":"Circulation"},{"key":"R43-20250526","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/1529-0131(199806)41:6<1096::AID-ART17>3.0.CO;2-Y","article-title":"Poststreptococcal reactive arthritis: clinical characteristics and association with HLA-DR alleles","volume":"41","author":"Ahmed","year":"1998","journal-title":"Arthritis Rheum"},{"key":"R44-20250526","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1542\/peds.93.5.837","article-title":"Poststreptococcal reactive arthritis and silent carditis: a case report and review of the literature","volume":"93","author":"Schaffer","year":"1994","journal-title":"Pediatrics"},{"key":"R45-20250526","first-page":"578","article-title":"Late cardiac assessment in children diagnosed with poststreptococcal reactive arthritis: a long term study","volume":"33","author":"Perl","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"R46-20250526","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1007\/s10067-019-04695-y","article-title":"Acute onset of psoriatic spondyloarthritis as a new manifestation of poststreptococcal reactive arthritis: a case series","volume":"38","author":"Dagan","year":"2019","journal-title":"Clin Rheumatol"},{"key":"R47-20250526","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/RHU.0b013e3180690c1f","article-title":"Use of adalimumab in poststreptococcal reactive arthritis","volume":"13","author":"Sanchez-Cano","year":"2007","journal-title":"J Clin Rheumatol"},{"key":"R48-20250526","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(11)60103-7","article-title":"Lyme borreliosis","volume":"379","author":"Stanek","year":"2012","journal-title":"Lancet"},{"key":"R49-20250526","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/BOR.0000000000000698","article-title":"Lyme disease: diagnosis and treatment","volume":"32","author":"Schoen","year":"2020","journal-title":"Curr Opin Rheumatol"},{"key":"R50-20250526","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJM198908313210906","article-title":"Lyme disease","volume":"321","author":"Steere","year":"1989","journal-title":"N Engl J Med"},{"key":"R51-20250526","doi-asserted-by":"crossref","first-page":"725","DOI":"10.7326\/0003-4819-107-5-725","article-title":"The clinical evolution of Lyme arthritis","volume":"107","author":"Steere","year":"1987","journal-title":"Ann Intern Med"},{"key":"R52-20250526","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nrrheum.2010.209","article-title":"A case revealing the natural history of untreated Lyme disease","volume":"7","author":"Schoen","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"R53-20250526","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41584-021-00648-5","article-title":"Lyme arthritis: linking infection, inflammation and autoimmunity","volume":"17","author":"Lochhead","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"R54-20250526","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/acr.24495","article-title":"Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease","volume":"73","author":"Lantos","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R55-20250526","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1001\/jama.2016.6888","article-title":"Treatment of Lyme disease","volume":"315","year":"2016","journal-title":"JAMA"},{"key":"R56-20250526","doi-asserted-by":"crossref","first-page":"e0207067","DOI":"10.1371\/journal.pone.0207067","article-title":"A systematic review on the impact of gestational Lyme disease in humans on the fetus and newborn","volume":"13","author":"Waddell","year":"2018","journal-title":"PLoS One"},{"key":"R57-20250526","first-page":"563","article-title":"Lyme Arthritis Infect Dis Clin North Am","volume":"36","author":"Arvikar","year":"2022"},{"key":"R58-20250526","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.idc.2015.02.004","article-title":"Diagnosis and treatment of Lyme arthritis","volume":"29","author":"Arvikar","year":"2015","journal-title":"Infect Dis Clin North Am"},{"key":"R59-20250526","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1002\/art.22131","article-title":"Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis","volume":"54","author":"Steere","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R60-20250526","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/art.1780340817","article-title":"Treatment of refractory chronic Lyme arthritis with arthroscopic synovectomy","volume":"34","author":"Schoen","year":"1991","journal-title":"Arthritis Rheum"},{"key":"R61-20250526","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/art.39866","article-title":"Autoimmune arthritides, rheumatoid arthritis, psoriatic arthritis, or peripheral spondyloarthritis following Lyme disease","volume":"69","author":"Arvikar","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"R62-20250526","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00296-013-2923-9","article-title":"Intraarticular corticosteroids in refractory childhood Lyme arthritis","volume":"34","author":"Nimmrich","year":"2014","journal-title":"Rheumatol Int"},{"key":"R63-20250526","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3899\/jrheum.180829","article-title":"Intraarticular glucocorticoid injection as second-line treatment for Lyme arthritis in children","volume":"46","author":"Horton","year":"2019","journal-title":"J Rheumatol"},{"key":"R64-20250526","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(88)92011-9","article-title":"Treatment of late Lyme borreliosis--randomised comparison of ceftriaxone and penicillin","volume":"1","author":"Dattwyler","year":"1988","journal-title":"Lancet"},{"key":"R65-20250526","first-page":"2025","article-title":"Lyme arthritis in children and adolescents: outcome 12\u200amonths after initiation of antibiotic therapy","volume":"27","author":"Bentas","year":"2000","journal-title":"J Rheumatol"},{"key":"R66-20250526","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1080\/17476348.2021.1927718","article-title":"Extrapulmonary tuberculosis","volume":"15","author":"Sharma","year":"2021","journal-title":"Expert Rev Respir Med"},{"key":"R67-20250526","doi-asserted-by":"crossref","first-page":"100377","DOI":"10.1016\/j.jctube.2023.100377","article-title":"Epidemiology and factors associated with extra-pulmonary tuberculosis in a low-prevalence area","volume":"32","author":"Rolo","year":"2023","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"R68-20250526","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s10067-013-2270-y","article-title":"Clinical features of Poncet's disease. From the description of 198 cases found in the literature","volume":"32","author":"Rueda","year":"2013","journal-title":"Clin Rheumatol"},{"key":"R69-20250526","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1136\/ard.2005.045229","article-title":"Positive anticyclic citrullinated proteins and rheumatoid factor during active lung tuberculosis","volume":"65","author":"Elkayam","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R70-20250526","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1002\/acr.22984","article-title":"Development of the American College of Rheumatology's rheumatoid arthritis electronic clinical quality measures","volume":"68","author":"Yazdany","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R71-20250526","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1093\/cid\/ciw376","article-title":"Executive Summary: Official American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America Clinical Practice Guidelines: treatment of drug-susceptible tuberculosis","volume":"63","author":"Nahid","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R72-20250526","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/art.22768","article-title":"Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection","volume":"57","author":"Gomez-Reino","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R73-20250526","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/1756-185X.12726","article-title":"A case series and review of Poncet's disease, and the utility of current diagnostic criteria","volume":"19","author":"Sharma","year":"2016","journal-title":"Int J Rheum Dis"},{"key":"R74-20250526","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1469-0691.2006.01366.x","article-title":"Infectious arthritis: clinical features, laboratory findings and treatment","volume":"12","author":"Smith","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"R75-20250526","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s10067-012-2042-0","article-title":"Poncet's disease (reactive arthritis associated with tuberculosis): retrospective case series and review of literature","volume":"31","author":"Abdulaziz","year":"2012","journal-title":"Clini Rheumatol"},{"key":"R76-20250526","doi-asserted-by":"crossref","first-page":"e18008","DOI":"10.1097\/MD.0000000000018008","article-title":"Reactive arthritis induced by active extra-articular tuberculosis: a case report","volume":"98","author":"Endo","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"R77-20250526","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.2169\/internalmedicine.9241-21","article-title":"Poncet's disease (reactive arthritis associated with tuberculosis)","volume":"61","author":"Higashiguchi","year":"2022","journal-title":"Intern Med"},{"key":"R78-20250526","first-page":"3571247","article-title":"Poncet's disease in the preclinical phase of rheumatoid arthritis","volume":"2018","author":"Nyo","year":"2018","journal-title":"Case Rep Rheumatol"},{"key":"R79-20250526","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.semarthrit.2018.03.011","article-title":"A systematic review of viral exposures as a risk for rheumatoid arthritis","volume":"48","author":"Kudaeva","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"R80-20250526","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/art.41994","article-title":"Antibody responses to Epstein-Barr virus in the preclinical period of rheumatoid arthritis suggest the presence of increased viral reactivation cycles","volume":"74","author":"Fechtner","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"R81-20250526","doi-asserted-by":"crossref","first-page":"101736","DOI":"10.1016\/j.berh.2021.101736","article-title":"Infectious mimics of rheumatoid arthritis","volume":"36","author":"Sharma","year":"2022","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R82-20250526","doi-asserted-by":"crossref","first-page":"129","DOI":"10.7861\/clinmedicine.16-2-129","article-title":"Viral arthritis","volume":"16","author":"Marks","year":"2016","journal-title":"Clin Med (Lond)"},{"key":"R83-20250526","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7326\/0003-4819-106-1-19","article-title":"The Co-occurrence of Reiter's Syndrome and Acquired Immunodeficiency","volume":"106","year":"1987","journal-title":"Ann Intern Med"},{"key":"R84-20250526","first-page":"11","article-title":"The pattern of postviral arthritis in COVID pandemic state: an experience of tertiary care centre","volume":"69","author":"Jaladhar","year":"2021","journal-title":"J Assoc Physicians India"},{"key":"R85-20250526","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1007\/s10067-020-05550-1","article-title":"Post-COVID-19 arthritis: a case report and literature review","volume":"40","author":"Gasparotto","year":"2021","journal-title":"Clin Rheumatol"},{"key":"R86-20250526","doi-asserted-by":"crossref","first-page":"e655","DOI":"10.1016\/S2665-9913(20)30348-9","article-title":"Viral arthritis and COVID-19","volume":"2","author":"Parisi","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"R87-20250526","first-page":"278","article-title":"Coronavirus Disease 19 (COVID-19) complicated with postviral arthritis","volume":"45","author":"Fragata","year":"2020","journal-title":"Acta Reumatol Port"},{"key":"R88-20250526","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/RHU.0b013e318214c119","article-title":"Routine screening for HIV in rheumatology practice","volume":"17","author":"Shah","year":"2011","journal-title":"JCR J Clin Rheumatol"},{"key":"R89-20250526","doi-asserted-by":"crossref","first-page":"101739","DOI":"10.1016\/j.berh.2021.101739","article-title":"Rheumatoid arthritis and HIV-associated arthritis: two sides of the same coin or different coins","volume":"36","author":"Maharaj","year":"2022","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R90-20250526","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nrrheum.2012.64","article-title":"Arthritogenic alphaviruses--an overview","volume":"8","author":"Suhrbier","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"R91-20250526","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1086\/605496","article-title":"Chikungunya fever: an epidemiological review of a re-emerging infectious disease","volume":"49","author":"Staples","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R92-20250526","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1111\/j.1742-1241.2011.02792.x","article-title":"Rheumatic-musculoskeletal pain and disorders in a naive group of individuals 15\u200amonths following a Chikungunya viral epidemic in south India: a population based observational study","volume":"65","author":"Mathew","year":"2011","journal-title":"Int J Clin Pract"},{"key":"R93-20250526","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/1471-2474-15-249","article-title":"Identification of initial severity determinants to predict arthritis after chikungunya infection in a cohort of French gendarmes","volume":"15","author":"Yaseen","year":"2014","journal-title":"BMC Musculoskelet Disord"},{"key":"R94-20250526","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/acr.22900","article-title":"Prevalence of post-chikungunya infection chronic inflammatory arthritis: a systematic review and meta-analysis","volume":"68","author":"Rodriguez-Morales","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R95-20250526","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.medmal.2015.05.007","article-title":"French guidelines for the management of chikungunya (acute and persistent presentations) November 2014","volume":"45","author":"Simon","year":"2015","journal-title":"Med Mal Infect"},{"key":"R96-20250526","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1177\/0973369820090303","article-title":"Comparative evaluation of four therapeutic regimes in chikungunya arthritis: a prospective randomized parallel-group study","volume":"4","author":"Padmakumar","year":"2009","journal-title":"Ind J Rheumatol"},{"key":"R97-20250526","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/RHU.0000000000000868","article-title":"Pan-American League of Associations for Rheumatology-Central American, Caribbean and Andean Rheumatology Association Consensus-Conference Endorsements and Recommendations on the Diagnosis and Treatment of Chikungunya-Related Inflammatory Arthropathies in Latin America","volume":"25","author":"Monge","year":"2019","journal-title":"J Clin Rheumatol"},{"key":"R98-20250526","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1590\/s1678-9946202365026","article-title":"Hydroxychloroquine for the management of chronic chikungunya arthritis","volume":"65","author":"Nogueira","year":"2023","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"R99-20250526","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1089\/vbz.2008.0049","article-title":"On chikungunya acute infection and chloroquine treatment","volume":"8","author":"De Lamballerie","year":"2008","journal-title":"Vector Borne Zoonotic Dis"},{"key":"R100-20250526","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s10067-016-3429-0","article-title":"Efficacy of combination DMARD therapy vs. hydroxychloroquine monotherapy in chronic persistent chikungunya arthritis: a 24-week randomized controlled open label study","volume":"36","author":"Ravindran","year":"2017","journal-title":"Clin Rheumatol"},{"key":"R101-20250526","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/acr.23519","article-title":"Treatment of chronic chikungunya arthritis with methotrexate: a systematic review","volume":"70","author":"Amaral","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R102-20250526","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1590\/1806-9282.64.01.63","article-title":"Treatment of chikungunya chronic arthritis: a systematic review","volume":"64","author":"Sales","year":"2018","journal-title":"Rev Assoc Med Bras"},{"key":"R103-20250526","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s10067-017-3766-7","article-title":"Management of chikungunya arthritis","volume":"36","author":"Kennedy Amaral Pereira","year":"2017","journal-title":"Clin Rheumatol"},{"key":"R104-20250526","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10156-008-0636-X","article-title":"Intravenous immunoglobulin therapy for severe arthritis associated with human parvovirus B19 infection","volume":"14","author":"Ogawa","year":"2008","journal-title":"J Infect Chemother"},{"issue":"(Suppl 2)","key":"R105-20250526","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1136\/annrheumdis-2018-eular.7378","article-title":"AB1050 Reactive arthritis due to parvovirus b19 may be overlooked in adult rheumatology","volume":"77","author":"Hutton","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R106-20250526","first-page":"e748","article-title":"Rheumatoid arthritis or parvovirus B19 arthritis?","volume":"7","author":"de Carvalho","year":"2021","journal-title":"Infect Dis Trop Med"},{"key":"R107-20250526","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/(SICI)1097-0142(19980915)83:6<1224::AID-CNCR23>3.0.CO;2-6","article-title":"Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies","volume":"83","author":"Zuckerman","year":"1998","journal-title":"Cancer"},{"key":"R108-20250526","first-page":"979","article-title":"Hepatitis C infection presenting with rheumatic manifestations: a mimic of rheumatoid arthritis","volume":"23","author":"Lovy","year":"1996","journal-title":"J Rheumatol"},{"key":"R109-20250526","first-page":"351","article-title":"Hepatitis C-related arthropathy: diagnostic and treatment considerations","volume":"27","author":"Kemmer","year":"2010","journal-title":"J Musculoskelet Med"},{"key":"R110-20250526","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/ar2480","article-title":"Virally associated arthritis 2008: clinical, epidemiologic, and pathophysiologic considerations","volume":"10","author":"Vassilopoulos","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"R111-20250526","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s13018-023-03651-6","article-title":"Reactive arthritis following COVID-19 current evidence, diagnosis, and management strategies","volume":"18","author":"Migliorini","year":"2023","journal-title":"J Orthop Surg Res"},{"key":"R112-20250526","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.reuma.2022.03.004","article-title":"Does post-COVID reactive arthritis exist? Experience of a tertiary care centre with a review of the literature","volume":"19","author":"Pal","year":"2023","journal-title":"Reumatol Clin"},{"key":"R113-20250526","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1258\/ijsa.2009.009400","article-title":"Reactive arthritis responding to antiretroviral therapy in an HIV-1-infected individual","volume":"23","author":"Scott","year":"2012","journal-title":"Int J STD AIDS"},{"key":"R114-20250526","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0014-5793(95)00057-G","article-title":"The nonsteroidal anti-inflammatory drug, indomethacin, as an inhibitor of HIV replication","volume":"360","author":"Bourinbaiar","year":"1995","journal-title":"FEBS Letters"},{"key":"R115-20250526","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/ard.2007.081513","article-title":"The use of antitumour necrosis factor therapy in HIV-positive individuals with rheumatic disease","volume":"67","author":"Cepeda","year":"2008","journal-title":"Ann Rheum Dis"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000001009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T21:17:51Z","timestamp":1748294271000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000001009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,21]]},"references-count":115,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000001009","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,21]]}}}